WR279,396, a Third Generation Aminoglycoside Ointment for the Treatment of Leishmania major Cutaneous Leishmaniasis: A Phase 2, Randomized, Double Blind, Placebo Controlled Study

BACKGROUND: Cutaneous leishmaniasis (CL) is a disfiguring disease that confronts clinicians with a quandary: leave patients untreated or engage in a complex or toxic treatment. Topical treatment of CL offers a practical and safe option. Accordingly, the treatment of CL with WR279,396, a formulation...

Descripción completa

Detalles Bibliográficos
Autores principales: Ben Salah, Afif, Buffet, Pierre A., Morizot, Gloria, Ben Massoud, Nathalie, Zâatour, Amor, Ben Alaya, Nissaf, Haj Hamida, Nabil Bel, Ahmadi, Zaher El, Downs, Matthew T., Smith, Philip L., Dellagi, Koussay, Grögl, Max
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2673687/
https://www.ncbi.nlm.nih.gov/pubmed/19415122
http://dx.doi.org/10.1371/journal.pntd.0000432

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2673687/
https://www.ncbi.nlm.nih.gov/pubmed/19415122
http://dx.doi.org/10.1371/journal.pntd.0000432

Ejemplares similares